Last updated on April 2019

A Study of Lenvatinib Plus Nivolumab in Participants With Hepatocellular Carcinoma


Brief description of study

The primary objective of this study is to evaluate the tolerability and safety of a combination of lenvatinib plus nivolumab in participants with hepatocellular carcinoma (HCC).

Clinical Study Identifier: NCT03418922

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.